The process for producing a nano-CBD liposome system in accordance of the present invention succeeds in manufacturing a liposome system having nano-CBD particles with dimensions smaller than 200 nm, uniformity and well-water solubility while retaining the structure and activity of CBD, the ability of absorption and the ability of storage will increase. CBD packaged in nanovehicle delivery systems helps transport to targets in a selectively, effectively and drug-saving way.
The present invention relates to a process for producing a nano-CBD liposome system.
Cannabidiol is an cannabinoid that is cyclohexene which is substituted by a methyl group at position 1, a 2,6-dihydroxy-4-pentylphenyl group at position 3, and a prop-1-en-2-yl group at position 4. Cannabidiol is a phytocannabinoid derived from Cannabis species, which is devoid of psychoactive activity, does not have psychophysiological activity and is applied in analgesic, anti-inflammatory, antineoplastic, and chemopreventive activities.
CBD has high activity in the body but low bioavailability. CBD has high lipophilicity and low stability (degradation via the effects of temperature, light and auto-oxidation can occur). Applying nano technologies is a novel technological application for generating vehicle systems and increasing the bioavailability of the agent.
The process for producing a nano-CBD microemulsion system of the present invention succeeds in manufacturing a microemulsion system having nano-CBD micelles with small dimensions of about 20 to 85 nm, which is uniform and good water-soluble while retains the structure, activity of CBDs in nanoprocessing.
The present invention relates to a process for producing a nano-CBD microemulsion system.
Cannabidiol is an cannabinoid that is cyclohexene which is substituted by a methyl group at position 1, a 2,6-dihydroxy-4-pentylphenyl group at position 3, and a prop-1-en-2-yl group at position 4. It has a role as a plant metabolite. It is a member of resorcinols, an olefinic compound and a phytocannabinoid. It acts as a plant metabolite. Cannabidiol is a phytocannabinoid derived from Cannabis species, devoid of psychoactive activity, does not have psychophysiological activity and is applied in analgesic, anti-inflammatory, antineoplastic, and chemopreventive activities.
